Details of the Drug
General Information of Drug (ID: DMIV04R)
| Drug Name |
Elpetrigine
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
ELPETRIGINE; 212778-82-0; JZP-4; 3-(2,3,5-trichlorophenyl)pyrazine-2,6-diamine; UNII-1X64S9H3ZS; 1X64S9H3ZS; 2,6-DIAMINO-3-(2,3,5-TRICHLOROPHENYL)PYRAZINE; 2,6-DIAMINO-3-(2,3,5-TRICHLOROPHENYL)-PYRAZINE; JZP4; Elpetrigine [USAN:INN]; Elpetrigine (USAN/INN); CHEMBL29919; SCHEMBL978547; ZINC9967; CTK0J9586; NNXUYJFHOVCRSM-UHFFFAOYSA-N; AKOS015966238; AN-29755; ACM212778820; D09609; 778D820; 2,6-Diamino-3-(2,3,5-trichlorophenyl) pyrazine; 2,6-Pyrazinediamine, 3-(2,3,5-trichlorophenyl)-; 2,6-Diamino-3- (2,3,5-trichlorophenyl) pyrazin
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 289.5 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


